Gastrointestinal stromal tumors

Gastrointestinal stromal tumors (GIST) are tumors of the GI tract derived from mesenchymal precursor cells in the gut wall. They result from mutations of a growth factor receptor gene, C-KIT. Some are caused by previous radiation therapy to the abdomen for other tumors.

Tumors are slow growing, and malignant potential varies from minimal to significant. Most (60 to 70%) occur in the stomach, 20 to 25% in the small bowel, and a small number in the esophagus, colon, and rectum. Average age at presentation is 50 to 60.

Symptoms vary with location but include bleeding, dyspepsia, and obstruction. Diagnosis is usually by endoscopy, with biopsy and endoscopic ultrasound for staging. Treatment is surgical removal. The role of radiation and chemotherapy is unclear, but the tyrosine kinase inhibitor imatinib has been beneficial.

check also

  Small-bowel tumors

  Polyps of the Colon and rectum

  Familial adenomatous polyposis

  Stomach cancer

  Esophageal tumor

  Penile and Urethral Carcinoma

Print Version
Tell-a-Friend

RELATED ARTICLES:

Racial differences in cancer care still unexplained   Primary driver of stomach cancer development identified   Birth control pills may lower colon cancer risk   Pancreatic cancer   Insulinoma - Pancreatic cancers   Pancreatic Endocrine Tumors   Zollinger-Ellison Syndrom - Pancreatic cancers   Vipoma - Pancreatic cancers   Glucagonoma - Pancreatic cancers   Small-bowel tumors   Polyps of the Colon and rectum   Familial adenomatous polyposis